Advances in Diagnosis and Treatment of Fetal Alcohol Spectrum Disorders: From Animal Models to Human Studies.
- Authors
- Murawski, Nathen J; Moore, Eileen M; Thomas, Jennifer D; Riley, Edward P
- Year
- 2015
- Journal
- Alcohol research : current reviews
- PMID
- 26259091
- DOI
- 10.35946/arcr.v37.1.07
- PMCID
- PMC4476607
Prenatal alcohol exposure can cause a number of physical, behavioral, cognitive, and neural impairments, collectively known as fetal alcohol spectrum disorders (FASD). This article examines basic research that has been or could be translated into practical applications for the diagnosis or treatment of FASD. Diagnosing FASD continues to be a challenge, but advances are being made at both basic science and clinical levels. These include identification of biomarkers, recognition of subtle facial characteristics of exposure, and examination of the relation between face, brain, and behavior. Basic research also is pointing toward potential new interventions for FASD involving pharmacotherapies, nutritional therapies, and exercise interventions. Although researchers have assessed the majority of these treatments in animal models of FASD, a limited number of recent clinical studies exist. An assessment of this literature suggests that targeted interventions can improve some impairments resulting from developmental alcohol exposure. However, combining interventions may prove more efficacious. Ultimately, advances in basic and clinical sciences may translate to clinical care, improving both diagnosis and treatment.
Craniofacial anomalies associated with alcohol exposure during development. (A) An illustration of a child with facial features of fetal alcohol syndrome (FAS). (B) Left figure shows a mouse with gestational day 7 alcohol exposure: Note small head, small eyes, and lack of a cleft under the nose compared with the control mouse on the right. (C) Zebrafish with embryonic alcohol exposure on the left compared with a control on the right. Again notice the small eyes, the smaller head, and the malformed body cavity and fin displacement resulting from alcohol exposure.SOURCE: Figure 1A: Warren et al. 2011.Photos in B are courtesy of Dr. Kathleen Sulik, University of North Carolina at Chapel Hill.Photos in C were taken from Marrs et al. 2010.
Indirect and direct markers of alcohol exposure. (A) Ideally, biomarkers could be both sensitive and specific to alcohol exposure and also indicate the timing and amount of alcohol exposure. This figure shows the period of time, or detection window, during which alcohol consumption can be detected and the lowest levels of alcohol consumption detectable by current alcohol biomarkers. For example, fatty acid ethyl esters are detectable in a variety of biological samples, such as neonatal hair and meconium, for several months after exposure. (B) MicroRNAs (miRNAs) may serve as potential biomarkers. Using a sheep model, Dr. Rajesh Miranda has identified several miRNAs that are modified by ethanol. As shown in this panel, miR-9 expression was significantly increased in plasma from the ethanol-exposed pregnant female compared with the control female but significantly decreased in plasma from neonatal lamb compared with controls. Alterations in miR-9 may be indicative of alcohol exposure in the mother, but also may serve as a marker of alcohol-induced injury in the neonate.SOURCE: Figure 2(A): Bakhireva and Savage 2011. Figure 2(B): Modified from Balaraman et al. 2014.NOTE: * = significantly different from control.
Three-dimensional facial imaging used to detect the effects of prenatal alcohol exposure. Each case shows face and philtrum (ridge under nose) shape as well as heat maps indicating significant regions of difference from age- and sex-matched control subjects. The control case shows an unexposed individual with some flattening across the nasal bridge, a small jaw and a strongly grooved philtrum. The heavily exposed (HE) case is an individual with known exposure without clinically recognized fetal alcohol syndrome (FAS). The overall face size is average or larger and the upper part of philtrum is smooth. The FAS case shows a reduced face size and philtrum smoothness, best revealed in the philtrum heat map; red at outer canthi (outer edge of eye) identifies narrow palpebral fissures.
Magnetic resonance imaging (MRI) images showing the differential effect of different timing of exposure on face shape and brain morphology. (A) The left panel shows a control, whereas the two other panels show animals exposed on gestation day 7 and gestation day 8.5. The different timing produces differential effects on face and brain. (B) An illustration of how the shape analysis shown in figure 3 can be applied to the mouse images. The left panel shows the difference between an animal exposed on gestation day 7 versus a control. Red areas indicate a reduction in size. The middle panel shows gestation day 8 exposure versus control, note the absence of many red areas. The right panel shows the difference between the two exposure times. (C) Ethanol interacts synergistically with the PDGFRA gene. The two left most figures show an intact embryo and the dissected neurocranium of a stained PDGFRA heterozygote displaying normal morphology of the neurocranium. The right most panel shows how ethanol severely disrupts development of the anterior neurocranium and palate of the zebrafish. The homozygote, −/−, (not shown) is even more affected.SOURCE: Photos in A and B are courtesy of Dr. Kathleen Sulik, University of North Carolina at Chapel Hill.Photos in C are courtesy of Dr. Johann Eberhart, University of Texas at Austin.
(A) Many children with fetal alcohol spectrum disorder (FASD) are not consuming adequate or recommended levels of nutrients (Fuglestad et al. 2013). (B) Rodent models have shown that postnatal supplementation with various nutrients, including vitamin D, choline, and omega-3 fatty acids can reduce the severity of FASD. As shown in B, prenatal alcohol exposure in a rodent model impaired hippocampal plasticity, as measured by reduced long-term potentiation (blue bars = normal diet), an effect attenuated with postnatal supplementation with omega-3 fatty acids (orange bars = omega-3 supplemented diet) (Patten, et al. 2013b). Such studies illustrate how preclinical and clinical studies may inform one another in the development of effective interventions for FASD.NOTE: * = significant group differences at p ≤ 0.05; ** = significant group differences at p ≤ 0.01)
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Meta-Analyses of Externalizing Disorders: Genetics or Prenatal Alcohol Exposure? | 2018 | 29063614 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Clinical insights into catechin-based nanomedicine: a review of therapeutic potential in neurodegenerative diseases. | Al Amin M et al. | — | 2025 | → |
| Environmental enrichment reverses prenatal ethanol exposure-induced attention-deficits in rats. | Wang R et al. | — | 2025 | → |
| Fetal alcohol spectrum disorder and health professionals' awareness of the syndrome: A comparison of practitioners' knowledge in two french regions. | Daoudi S et al. | — | 2025 | → |
| Development, Insults and Predisposing Factors of the Brain's Predictive Coding System to Chronic Perceptual Disorders-A Life-Course Examination. | Yasoda-Mohan A et al. | — | 2024 | → |
| Fetal Alcohol Spectrum Disorder: The Honey Bee as a Social Animal Model. | Camilli MP et al. | — | 2024 | → |
| New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature. | Olivares-Costa M et al. | — | 2024 | → |
| Prenatal Alcohol Exposure and Metabolic Disorders in Pediatrics: The Role of the Oxidative Stress-A Review of the Literature. | Derme M et al. | — | 2024 | → |
| Differential Early Mechanistic Frontal Lobe Responses to Choline Chloride and Soy Isoflavones in an Experimental Model of Fetal Alcohol Spectrum Disorder. | de la Monte SM et al. | — | 2023 | → |
| Differential rescue effects of choline chloride and soy isolate on metabolic dysfunction in immature central nervous system neurons: Relevance to fetal alcohol spectrum disorder. | de la Monte SM et al. | — | 2023 | → |
| Oxidative Stress in a Mother Consuming Alcohol during Pregnancy and in Her Newborn: A Case Report. | Derme M et al. | — | 2023 | → |
| Significance of Selected Environmental and Biological Factors on the Risk of FASD in Women Who Drink Alcohol during Pregnancy. | Grzywacz E et al. | — | 2023 | → |
| Effect of Embryonic Alcohol Exposure on Craniofacial and Skin Melanocyte Development: Insights from Zebrafish (<i>Danio rerio</i>). | Azimian Zavareh P et al. | — | 2022 | → |
| Fetal Alcohol Spectrum Disorder in a Newborn. | Patel T et al. | — | 2022 | → |
| Influence of <i>COMT</i> (rs4680) and <i>DRD2</i> (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders. | Śmiarowska M et al. | — | 2022 | → |
| Postnatal Choline Supplementation Rescues Deficits in Synaptic Plasticity Following Prenatal Ethanol Exposure. | Grafe EL et al. | — | 2022 | → |
| Prenatal ethanol exposure impairs sensory processing and habituation to visual stimuli, effects normalized by enrichment of postnatal environmental. | Wang R et al. | — | 2022 | → |
| Review of rodent models of attention deficit hyperactivity disorder. | Regan SL et al. | — | 2022 | → |
| Altering Cell-Cell Interaction in Prenatal Alcohol Exposure Models: Insight on Cell-Adhesion Molecules During Brain Development. | Licheri V et al. | — | 2021 | → |
| Corticostriatal Circuit Models of Cognitive Impairments Induced by Fetal Exposure to Alcohol. | Bariselli S et al. | — | 2021 | → |
| Evaluation of the German biographic screening interview for fetal alcohol spectrum disorder (BSI-FASD). | Widder M et al. | — | 2021 | → |
| Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders. | Sebastiani G et al. | — | 2021 | → |
| Alcohol consumption before pregnancy causes detrimental fetal development and maternal metabolic disorders. | Lee YJ et al. | — | 2020 | → |
| Animal models of gene-alcohol interactions. | Lovely CB | — | 2020 | → |
| Embryonic Exposure to Ethanol Increases Anxiety-Like Behavior in Fry Zebrafish. | Pinheiro-da-Silva J et al. | — | 2020 | → |
| Environmental Enrichment During Adolescence Mitigates Cognitive Deficits and Alcohol Vulnerability due to Continuous and Intermittent Perinatal Alcohol Exposure in Adult Rats. | Brancato A et al. | — | 2020 | → |
| Murine Models for the Study of Fetal Alcohol Spectrum Disorders: An Overview. | Almeida L et al. | — | 2020 | → |
| Cholinergic rescue of neurocognitive insult following third-trimester equivalent alcohol exposure in rats. | Heroux NA et al. | — | 2019 | → |
| Comparison of the 4-Digit Code, Canadian 2015, Australian 2016 and Hoyme 2016 fetal alcohol spectrum disorder diagnostic guidelines. | Hemingway SJA et al. | — | 2019 | → |
| Differentially sensitive neuronal subpopulations in the central nervous system and the formation of hindbrain heterotopias in ethanol-exposed zebrafish. | Buckley DM et al. | — | 2019 | → |
| Fetal alcohol spectrum disorders - diagnostic difficulties in the neonatal period and new diagnostic approaches. | Jańczewska I et al. | — | 2019 | → |
| Fetal Cerebral Artery Mitochondrion as Target of Prenatal Alcohol Exposure. | Bukiya AN | — | 2019 | → |
| Neonatal ethanol exposure impairs long-term context memory formation and prefrontal immediate early gene expression in adolescent rats. | Heroux NA et al. | — | 2019 | → |
| Oxidative Stress-Induced Brain Damage Triggered by Voluntary Ethanol Consumption during Adolescence: A Potential Target for Neuroprotection? | Buján GE et al. | — | 2019 | → |
| Proteomic Analysis of Baboon Cerebral Artery Reveals Potential Pathways of Damage by Prenatal Alcohol Exposure. | Bisen S et al. | — | 2019 | → |
| Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies. | Hetman M et al. | — | 2019 | → |
| Environmental enrichment reverses increased addiction risk caused by prenatal ethanol exposure. | Wang R et al. | — | 2018 | → |
| Experiences of living with fetal alcohol spectrum disorders: a systematic review and synthesis of qualitative data. | Domeij H et al. | — | 2018 | → |
| Fetal Cerebral Circulation as Target of Maternal Alcohol Consumption. | Bukiya AN et al. | — | 2018 | → |
| Hippocampus-dependent memory and allele-specific gene expression in adult offspring of alcohol-consuming dams after neonatal treatment with thyroxin or metformin. | Tunc-Ozcan E et al. | — | 2018 | → |
| Meta-Analyses of Externalizing Disorders: Genetics or Prenatal Alcohol Exposure? | Wetherill L et al. | — | 2018 | → |
| Perceptions of Fetal Alcohol Spectrum Disorder (FASD) at a Mental Health Outpatient Treatment Provider in Minnesota. | Brown J et al. | — | 2018 | → |
| Postnatal nutritional treatment of neurocognitive deficits in fetal alcohol spectrum disorder. | Bastons-Compta A et al. | — | 2018 | → |
| Prenatal influences on temperament development: The role of environmental epigenetics. | Gartstein MA et al. | — | 2018 | → |
| Antagonism of muscarinic acetylcholine receptors in medial prefrontal cortex disrupts the context preexposure facilitation effect. | Robinson-Drummer PA et al. | — | 2017 | → |
| Applying evolutionary genetics to developmental toxicology and risk assessment. | Leung MCK et al. | — | 2017 | → |
| Epigenetics studies of fetal alcohol spectrum disorder: where are we now? | Lussier AA et al. | — | 2017 | → |
| Fetal Alcohol Spectrum Disorders: Characteristics, Complications, and Treatment. | Wilhoit LF et al. | — | 2017 | → |
| Gene-environment interactions in development and disease. | Lovely C et al. | — | 2017 | → |
| Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via endocannabinoid receptors. | Seleverstov O et al. | — | 2017 | → |
| Mouth development. | Chen J et al. | — | 2017 | → |
| Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders. | Davis-Anderson KL et al. | — | 2017 | → |
| Self-reported health, use of alcohol and illicit drugs, and criminality among adults with foetal alcohol syndrome. | Rangmar J et al. | — | 2017 | → |
| Commentary: Linking Cortical and Subcortical Developmental Trajectories to Behavioral Deficits in a Mouse Model of Prenatal Alcohol Exposure. | Weinberg J | — | 2016 | → |
| Preclinical Medication Development: New Targets and New Drugs. | Kasten CR et al. | — | 2016 | → |
| The Impact of Prenatal Ethanol Exposure on Neuroanatomical and Behavioral Development in Mice. | Abbott CW et al. | — | 2016 | → |
| Third Trimester Equivalent Alcohol Exposure Reduces Modulation of Glutamatergic Synaptic Transmission by 5-HT1A Receptors in the Rat Hippocampal CA3 Region. | Morton RA et al. | — | 2016 | → |
| Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells. | Tong M et al. | — | 2013 | → |